Cargando…
Asia‐Pacific Consensus Recommendations on X‐Linked Hypophosphatemia: Diagnosis, Multidisciplinary Management, and Transition From Pediatric to Adult Care
X‐linked hypophosphatemia (XLH) is a rare, inherited, multisystem disorder characterized by hypophosphatemia that occurs secondary to renal phosphate wasting. Mutations in PHEX gene (located at Xp22.1) in XLH alter bone mineral metabolism, resulting in diverse skeletal, dental, and other extraskelet...
Autores principales: | Munns, Craig F, Yoo, Han‐Wook, Jalaludin, Muhammad Yazid, Vasanwala, Rashida, Chandran, Manju, Rhee, Yumie, BUT, Wai Man, Kong, Alice Pik‐Shan, Su, Pen‐Hua, Numbenjapon, Nawaporn, Namba, Noriyuki, Imanishi, Yasuo, Clifton‐Bligh, Roderick J, Luo, Xiaoping, Xia, Weibo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241092/ https://www.ncbi.nlm.nih.gov/pubmed/37283655 http://dx.doi.org/10.1002/jbm4.10744 |
Ejemplares similares
-
FGF23, Hypophosphatemia, and Emerging Treatments
por: Imel, Erik A, et al.
Publicado: (2019) -
Molecular Bases of Diseases Characterized by Hypophosphatemia and
Phosphaturia: New Understanding
por: Ozono, Keiichi, et al.
Publicado: (2006) -
Craniosynostosis in Patients With X‐Linked Hypophosphatemia: A Review
por: Munns, Craig F, et al.
Publicado: (2023) -
OR13-2 Burosumab Resulted in Greater Improvement in Rickets Than Conventional Therapy in Children with X-Linked Hypophosphatemia (XLH)
por: Imel, Erik, et al.
Publicado: (2019) -
Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia
por: Ward, Leanne M, et al.
Publicado: (2022)